Henry Ford Hospital Infectious Disease

Topics

• Antimicrobial Resistance in Staphylococcus 167
• Antifungal resistance and susceptibility 48
• COVID-19 Clinical Research Studies 36
• Antibiotic Resistance in Bacteria 30
• Clostridium difficile and Clostridium perfringens research 30
• Antibiotic Use and Resistance 29
• Infective Endocarditis Diagnosis and Management 21
• Fungal Infections and Studies 20
• Pneumonia and Respiratory Infections 20
• SARS-CoV-2 and COVID-19 Research 19
• Urinary Tract Infections Management 19
• HIV/AIDS drug development and treatment 18

Most cited

1. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.

   The Lancet. Microbe · 2023 · 265 citations · Erica Herc

2. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.

   The New England journal of medicine · 2021 · 495 citations · Marcus Zervos

3. Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026 · 41 citations · Mayur Ramesh

4. Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral Drugs.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · 248 citations · Louis Saravolatz

5. Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024 · 93 citations · Erica Herc

6. Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study.